Once in a lifetime OpportunityFSGS cure in the making.
-Phase 3 results coming mid 2025.
- DXB has been working on this since 2012 trialing
-Estimated 200k people in the world have this disease and increasing.
- Recently did a CR at 0.3
Safe to say if suceed the market is enormous with a great chance to become a 20 bagger.
DXB trade ideas
DXB - setting up nicely - BullishKey Technicals - flag/ascending triangle, entry on breakout.
Key Fundamentals - the Australian Government’s Medical Research Future Fund (MRFF) through the
Biomedical Translation Bridge (BTB) program is supporting development and clinical evaluation of
DMX-200 as a new treatment for respiratory complications as a result of COVID-19 in global clinical
study with a potential fast track pathway to clinical practice.